PharmaBoardroom

Interview with Victor Pedroza, Managing Director Mexico, Baxter…

Baxter established itself in Mexico as early as 1948 through the acquisition of a local manufacturer, Madom’s Pharmaceutical. In a vast market…

Interview with Mario Sicilia , CEO, Bomi de Mexico

You took over BOMI as President and CEO only last year. Could you give us a brief background on BOMI Mexico and yourself? BOMI Mexico was founded in…

Stengthening Guidelines for Biosimilars in Mexico

Despite being in the Mexican market for over twenty years, biosimilars have never been regulated as a separate entity. They have always been regulated…

Interview with Tim Daveler, General Manager, MSD Mexico

We read in an article by El Economista last year that you believe “there is no other company with such a diverse range of therapies as MSD and…

Interview with Ricardo Alvarez Tostado, CEO, AstraZeneca Mexico

There have been a lot of changes in the Mexican pharmaceutical industry in the last four to five years, most notably the new drug registration process…

Interview with Bertrand Baron, CEO, Sanofi Mexico

Sanofi acquired Kendrick in 2009. Obviously the thinking behind it was to diversify your products into pure generics, but what were the expectations…

Interview with Joel Duran Chavez, Marketing Director, Novo…

Mexico is number one in child obesity and number two in adult obesity in the world. This is one of the reasons that diabetes is rapidly increasing and…

Interview with Aristides Torres Velasco, CEO, Vanquish Mexico

Can you give us a brief history of the company since your merger in 2003: the main growth drivers, opportunities and challenges? Laboratorios…

Interview with Israel Garcia Crespo, General Manager, Almirall…

Please can you give us a brief rundown of the last few years in the Mexican pharmaceutical and how the various regulation changes such as the new drug…